In accordance with the Measures for the Supervision and Administration of Unlisted Public Companies, the Rules for Directed Issuance of Stocks in the National Small and Medium-sized Enterprise Stock Transfer System, the Business Guidelines for Directed Issuance of Stocks in the National Small and Medium-sized Enterprise Stock Transfer System and other relevant laws and regulations. Rules for Directed Issuance of Stocks in the National Small and Medium-sized Enterprise Stock Transfer System, Business Guidelines for Directed Issuance of Stocks in the National Small and Medium-sized Enterprise Stock Transfer System, and other relevant laws, regulations and standardized documents, the Board of Directors of KEYU conducted a special verification of the deposit and actual utilization of the proceeds for the year 2022, and hereby reports the relevant information as follows. 

On January 24, 2022, the Company held the tenth meeting of the second session of the Board of Directors and the seventh meeting of the second session of the Supervisory Committee. The meeting considered and passed the Prospectus for Directed Stock Issuance of Zhuhai Techland Bioengineering Co. and was passed on February 10, 2022 at the first extraordinary general meeting of 2022 of the Company.

On March 10, 2022, the National Small and Medium-sized Enterprises Stock Transfer System Limited Liability Company issued the "Letter on the Letter of No Objection to the Directed Stock Offering of KEYU (Stock Transfer System Letter No. [2022]493).

As at March 24, 2022 (the payment deadline), a total of 8 subscribers participated in the subscription, and the subscribers had deposited all subscription funds of RMB12,500,000.00 into the special account for fund-raising approved for the Directed Issue. On April 7, 2022, the Zhuhai Branch of Lixin Certified Public Accountants (Special Ordinary Partnership) conducted a capital verification of the directed issue of shares. On 7 April 2022, Zhuhai Branch of Lixin Certified Public Accountants (Special Ordinary Partnership) conducted a capital verification of the Directed Issue of Shares and issued the Capital Verification Report (Xinhui Shi Ruizi [2022] No. ZM10017). (ZM10017).

On April 22, 2022, the Company disclosed the "Report on the Directional Issuance of Shares of Zhuhai KEYU (Announcement No. 2022-019) on the designated information disclosure platform of the National Small and Medium-sized Enterprises Stock Transfer System (www.neeq.com.cn), and the actual number of shares issued this time was 2,500,000 shares, and the price per share was RMB5.00 per share. The actual number of shares issued was 2,500,000 shares and the price per share was RMB5.00 per share, and the actual total proceeds raised amounted to RMB12,500,000.00. Proceeds The use of the proceeds is for repayment of bank loans and replenishment of working capital. On April 28, 2022, the new shares issued by the Company were listed on the National Small and Medium-sized Enterprises Stock Transfer System and publicly transferred.

In order to standardize the management of the Company's fund-raising, improve the efficiency of fund-raising and protect the legitimate rights and interests of investors. In accordance with the requirements of relevant regulations, the Company has formulated the "Collection Fund Management System of Zhuhai KEYU (hereinafter referred to as the "Fund Raising Management System"), which was considered and approved by the Tenth Meeting of the Second Session of the Board of Directors and the First Extraordinary General Meeting of 2022. (hereinafter referred to as the "Fund Raising Management System"), which was considered and approved by the Tenth Meeting of the Second Board of Directors and the First Extraordinary General Meeting of 2022. The Fund Raising Funds Management System specifies the hierarchical approval authority, decision-making procedures, and the procedures for the use of fund raising funds. The "Fund Raising Management System" specifies the hierarchical approval authority, decision-making procedures, risk control measures and information disclosure requirements for the use of fund raising.

For this directional offering, the Company has set up a special account for the proceeds and signed the "Tripartite Supervision of the Special Account for Proceeds" with Open Source Securities Co. Ltd. and Agricultural Bank of China Limited, Zhuhai Gongbei Sub-branch, and has signed the "Tripartite Supervision Agreement on Special Account for Proceeds". Ltd. and Agricultural Bank of China Limited, Zhuhai Gongbei Sub-branch, and has set up a special account for fund-raising funds.

In the process of actual use of raised funds, the Company strictly fulfills the procedures for approval of use and supervises and manages the use of raised funds in accordance with laws and regulations, the Articles of Association and relevant provisions of the Raised Funds Management System. The Company strictly fulfills the approval procedures for the use of the proceeds in the actual use of the proceeds, and supervises and manages the use of the proceeds in accordance with the laws and regulations, the Articles of Association of the Company and the relevant provisions of the Proceeds Collection Management System. The Company will supervise and manage the use of the proceeds in accordance with laws and regulations, the Articles of Association of the Company and the relevant provisions of the fund-raising management system to ensure that the funds are used exclusively.

As of December 31, 2022, the Company has used the proceeds in accordance with the use of proceeds disclosed in the Prospectus for Directed Issue of Zhuhai Keyu Biological Engineering Co., Ltd As at 31 December 2022, the Company had utilized the proceeds in accordance with the use of proceeds as disclosed in the "Prospectus for Directed Issue of Shares of KEYU. The Company has not changed the use of the proceeds.

The Company has established an internal control system for the storage, use, supervision and accountability of fund-raising funds, which specifies the hierarchical approval authority for the use of fund-raising funds, decision-making procedures, risk control measures and information disclosure requirements. The Company has established an internal control system for the storage, use and accountability of fund-raising funds, which specifies the hierarchical approval authority, decision-making procedures, risk control measures and information disclosure requirements for the use of funds raised. The Company has established an internal control system for the storage and use of fund-raising The storage and actual use of the Company's fund-raising are in compliance with the "Business Guidelines for Directed Issuance of Shares of National Small and Medium-sized Enterprises Stock Transfer System" and "Business Guidelines for Directed Issuance of Shares of National Small and Medium-sized Enterprises Stock Transfer System". The deposit and actual use of the Company's fund-raising are in compliance with the "Business Guidelines for Directed Stock Issuance of National Small and Medium-sized Enterprises Stock Transfer System", "Business Rules for Directed Stock Issuance of National Small and Medium-sized Enterprises Stock Transfer System" and other relevant laws, regulations and There are no irregularities in the deposit and use of fund-raising funds.